Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricSTESterisZBHZimmer BiometDXCMDexcom
Snapshot
Price$233.37$100.44$90.10
Market cap$21.27B$17.28B$27.49B
Valuation
P/E29.1x25.5x37.7x
Forward P/E22.8x29.9x26.9x
Growth
Revenue growth8.7%9.2%16.1%
EPS growth27.9%-14.6%77.5%
Profitability
Net margin13.2%9.1%19.3%
ROE11.1%6.0%33.8%
Balance sheet & cash
Debt / equity0.27x0.59x0.47x
Free cash flow yield5.4%7.5%1.8%
Dividend yield1.2%1.0%—
Verdict
Investment ratingFavorable· 59Neutral· 44Favorable· 70

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearSTEtoday $233ZBHtoday $100DXCMtoday $90
2027$223.95 – $328.46+41% CAGR$76.84 – $112.69+12% CAGR$119.91 – $175.87+95% CAGR
2028$286.54 – $420.26+34% CAGR$78.37 – $114.95+7% CAGR$212.78 – $312.08+86% CAGR
2029$366.63 – $537.72+32% CAGR$79.94 – $117.25+5% CAGR$377.58 – $553.79+83% CAGR
2030$469.10 – $688.02+31% CAGR$81.54 – $119.59+4% CAGR$670.02 – $982.70+82% CAGR
2031$600.22 – $880.32+30% CAGR$83.17 – $121.98+4% CAGR$1,188.96 – $1,743.80+81% CAGR
5-yr CAGR20.8% – 30.4%-3.7% – 4.0%67.5% – 80.9%